Oral Tirzepatide Tablets | No Injections | Dual GIP/GLP-1 | Luma Health
Dual GIP + GLP-1 · Oral Option

Most powerful.
No needles.

The dual-action power of Tirzepatide — the same active ingredient as Mounjaro® — now available as a simple daily tablet. Up to 22% body weight reduction, no injections required.*

💊 Same active ingredient as Mounjaro®  ·  Daily tablet
Dual-action:  GIP + GLP-1 · No injections, ever
$100/month · Includes medication, provider visits & 24/7 support
22%
Avg. Body Weight Lost*
Daily
Once-a-Day Tablet
Rx
Physician-Prescribed
Oral Tirzepatide tablets
How It Works

Dual-action science.
Pill-form simplicity.

Oral Tirzepatide activates both GIP and GLP-1 receptors — the same powerful dual mechanism as the injectable — delivered in a once-daily tablet.

01
🎯

Dual Receptor Action

Activates both GIP and GLP-1 receptors simultaneously — amplifying appetite suppression and metabolic benefits far beyond a single-receptor approach.

02
🔥

Boosts Metabolism

GIP receptor activation improves how your body processes fat and glucose — increasing energy expenditure and helping your metabolism work more efficiently every day.

03
📉

Crushes Cravings

The combined hormonal effect delivers stronger, more sustained appetite suppression — making it significantly easier to maintain a calorie deficit without feeling deprived.

22%
Average Body Weight Reduction
*Based on 6-month clinical study data
~47 lbs
Potential Loss at 215 lbs Starting Weight
*Individual results will vary
0
Injections Required — Ever
*Just one tablet, once a day
Safety

What to expect.

Oral Tirzepatide is safe and well-tolerated by most patients. Side effects are typically mild and improve as your body adjusts.

🟡 Common Side Effects

  • Nausea (especially in early weeks)
  • Reduced appetite
  • Mild constipation or diarrhea
  • Headache during dose adjustment
  • Mild fatigue early on
These are usually temporary and reduce significantly after the first few weeks. Your provider starts you at a low dose to help your body adjust comfortably.

✅ You're Supported

  • Same-day provider visits
  • 24/7 care team messaging
  • Dose adjusted to your body's response
  • FSA & HSA eligible
  • Payment plans via Affirm available
Your Luma provider monitors you throughout. Message your care team any time if you have questions or concerns.
FAQ

Common
questions.

More questions? Email [email protected]

Oral Tirzepatide contains the same active ingredient and activates the same dual GIP/GLP-1 pathways as the injectable. Clinical results are comparable. Your provider will determine the right formulation and dose based on your individual health profile and goals.

Oral Tirzepatide activates two hormone receptors — GIP and GLP-1 — while Oral Semaglutide targets GLP-1 only. This dual-action mechanism leads to stronger appetite suppression and greater average weight loss (up to 22% vs ~15%) in clinical trials.*

Oral Tirzepatide is taken once daily as a tablet — ideally in the morning on an empty stomach with a small amount of water. Full instructions are included with every shipment and your provider will guide you through the process.

Most patients notice significantly reduced appetite within the first 1–2 weeks. Visible weight loss typically begins by weeks 4–8, with the most dramatic results occurring between months 3–6 as your dose reaches its therapeutic level.

Yes to both. All Luma Health treatments are FSA and HSA eligible. We also accept Affirm — split your costs into simple monthly payments with no hidden fees, approved in seconds at checkout.

Maximum results.
Zero needles.

Complete a short health assessment and meet with a licensed provider today — same day visits available.